Jeff Posakony

1.8k total citations
25 papers, 1.5k citations indexed

About

Jeff Posakony is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Jeff Posakony has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Jeff Posakony's work include Sirtuins and Resveratrol in Medicine (5 papers), Synthesis and Catalytic Reactions (3 papers) and Porphyrin and Phthalocyanine Chemistry (3 papers). Jeff Posakony is often cited by papers focused on Sirtuins and Resveratrol in Medicine (5 papers), Synthesis and Catalytic Reactions (3 papers) and Porphyrin and Phthalocyanine Chemistry (3 papers). Jeff Posakony collaborates with scholars based in United States, Canada and South Africa. Jeff Posakony's co-authors include Julian A. Simon, Antonio Bedalov, Maki Hirao, Aaron D. Schuler, Timothy J. Tewson, Ramya Kollipara, Birgit Heltweg, Ronald A. DePinho, Hongzhe Li and Yansong Gu and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

Jeff Posakony

25 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeff Posakony United States	16	658	479	297	288	197	25	1.5k
Mallika Alvala India	25	766 1.2×	125 0.3×	101 0.3×	689 2.4×	146 0.7×	68	1.6k
Arunasree M. Kalle India	22	662 1.0×	80 0.2×	74 0.2×	735 2.6×	174 0.9×	43	1.7k
Po Hu China	18	698 1.1×	53 0.1×	93 0.3×	112 0.4×	147 0.7×	35	1.1k
Rossella Fioravanti Italy	27	839 1.3×	44 0.1×	153 0.5×	1.1k 3.8×	166 0.8×	75	2.3k
Robert M. Snapka United States	22	1.1k 1.7×	87 0.2×	66 0.2×	308 1.1×	443 2.2×	44	1.5k
Gerd K. Wagner United Kingdom	26	1.1k 1.6×	29 0.1×	107 0.4×	961 3.3×	145 0.7×	82	1.9k
Piia Kokkonen Czechia	12	665 1.0×	71 0.1×	53 0.2×	94 0.3×	57 0.3×	15	953
Athanasios Papakyriakou Greece	27	1.0k 1.5×	32 0.1×	284 1.0×	410 1.4×	681 3.5×	95	2.1k
Chih-Hua Tseng Taiwan	27	826 1.3×	48 0.1×	88 0.3×	891 3.1×	195 1.0×	86	1.9k

Countries citing papers authored by Jeff Posakony

Since Specialization

Citations

This map shows the geographic impact of Jeff Posakony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Posakony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Posakony more than expected).

Fields of papers citing papers by Jeff Posakony

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Posakony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Posakony. The network helps show where Jeff Posakony may publish in the future.

Co-authorship network of co-authors of Jeff Posakony

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Posakony. A scholar is included among the top collaborators of Jeff Posakony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Posakony. Jeff Posakony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cashman, Kathleen A., Eric R. Wilkinson, Jeff Posakony, et al.. (2022). Lassa antiviral LHF-535 protects guinea pigs from lethal challenge. Scientific Reports. 12(1). 19911–19911. 8 indexed citations

Amberg, Sean M., et al.. (2022). Safety and Pharmacokinetics of LHF-535, a Potential Treatment for Lassa Fever, in Healthy Adults. Antimicrobial Agents and Chemotherapy. 66(11). e0095122–e0095122. 8 indexed citations

Guillaudeux, Thierry, Eric J. Tarcha, Nathan Eyde, et al.. (2021). Abstract 1637: A fully human anti-vista antibody as a promising therapy against poorly immunogenic tumors. Cancer Research. 81(13_Supplement). 1637–1637. 3 indexed citations

Iadonato, Shawn P., Eric J. Tarcha, Nathan Eyde, et al.. (2020). 76P Highly potent fully human anti-VISTA antibodies efficiently abrogate the interaction of this new target checkpoint inhibitor to its different putative receptors at different pH. Annals of Oncology. 31. S1448–S1449. 1 indexed citations

Loo, Yueh–Ming, Courtney Wilkins, Sowmya Pattabhi, et al.. (2016). RIG-ging the host innate immune response for vaccine adjuvant and antiviral therapy. The Journal of Immunology. 196(1_Supplement). 76.3–76.3. 1 indexed citations

Mercado, Jose, Mingming Xu, Kevin Norton, et al.. (2016). (421) A novel, non-opioid, conesnail peptide-based analgesic as a therapeutic alternative for the treatment of chronic pain. Journal of Pain. 17(4). S79–S80. 1 indexed citations

Pattabhi, Sowmya, Courtney Wilkins, Ran Dong, et al.. (2015). Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway. Journal of Virology. 90(5). 2372–2387. 56 indexed citations

Mahajan, Sumit, Michele Scian, Smitha Sripathy, et al.. (2014). Development of Pyrazolone and Isoxazol-5-one Cambinol Analogues as Sirtuin Inhibitors. Journal of Medicinal Chemistry. 57(8). 3283–3294. 110 indexed citations

Vermillion, Karl E., F. Omar Holguín, Mark A. Berhow, et al.. (2011). Dinoxin B, a Withanolide from Datura inoxia Leaves with Specific Cytotoxic Activities. Journal of Natural Products. 74(2). 267–271. 27 indexed citations

10.

Chi, Yong, et al.. (2008). Identification of CDK2 substrates in human cell lysates. Genome biology. 9(10). R149–R149. 134 indexed citations

11.

Heltweg, Birgit, Tonibelle Gatbonton, Aaron D. Schuler, et al.. (2006). Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes. Cancer Research. 66(8). 4368–4377. 400 indexed citations

12.

Lucero, Mary E., F. Omar Holguín, Rick E. Estell, et al.. (2005). Composition and Antimicrobial Activity of Anemopsis californica Leaf Oil. Journal of Agricultural and Food Chemistry. 53(22). 8694–8698. 59 indexed citations

13.

Bonham, Michael, Jeff Posakony, Ilsa M. Coleman, et al.. (2005). Characterization of Chemical Constituents inScutellaria baicalensiswith Antiandrogenic and Growth-Inhibitory Activities toward Prostate Carcinoma. Clinical Cancer Research. 11(10). 3905–3914. 111 indexed citations

14.

Hirao, Maki, et al.. (2003). Identification of Selective Inhibitors of NAD+-dependent Deacetylases Using Phenotypic Screens in Yeast. Journal of Biological Chemistry. 278(52). 52773–52782. 61 indexed citations

15.

Bedalov, Antonio, et al.. (2003). NAD⁺-Dependent Deacetylase Hst1p Controls Biosynthesis and Cellular NAD⁺ Levels in Saccharomyces cerevisiae. Molecular and Cellular Biology. 23(19). 7044–7054. 110 indexed citations

16.

Posakony, Jeff & Timothy J. Tewson. (2002). Fluoroamines via Chiral Cyclic Sulfamidates. Synthesis. 2002(6). 766–770. 25 indexed citations

17.

Posakony, Jeff, John R. Grierson, & Timothy J. Tewson. (2002). New Routes to N-Alkylated Cyclic Sulfamidates. The Journal of Organic Chemistry. 67(15). 5164–5169. 38 indexed citations

18.

Korbelik, Mladen, et al.. (2001). Interaction Between Photodynamic Therapy and BCG Immunotherapy Responsible for the Reduced Recurrence of Treated Mouse Tumors¶. Photochemistry and Photobiology. 73(4). 403–403. 42 indexed citations

19.

Brückner, Christian, et al.. (1998). Novel and Improved Syntheses of 5,15-Diphenylporphyrin and its Dipyrrolic Precursors. Journal of Porphyrins and Phthalocyanines. 2(6). 455–465. 94 indexed citations

20.

James, Brian R., et al.. (1996). Porphyrins and Metalloporphyrins: Potential Hypoxic Agents. Metal-Based Drugs. 3(2). 85–89. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact